SARS-CoV-2: the many pros of targeting PLpro
Signal Transduct Target Ther
.
2020 Oct 6;5(1):223.
doi: 10.1038/s41392-020-00335-z.
Authors
Christopher B McClain
1
2
,
Nicolas Vabret
3
4
Affiliations
1
Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
2
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
3
Department of Medicine, Hematology and Medical Oncology, Icahn School of Medicine at Mount Sinai, New York, NY, USA. nicolas.vabret@mssm.edu.
4
Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. nicolas.vabret@mssm.edu.
PMID:
33024071
PMCID:
PMC7537779
DOI:
10.1038/s41392-020-00335-z
No abstract available
Publication types
Comment
MeSH terms
Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Immunity, Innate
Pandemics*
Papain*
Pneumonia, Viral*
SARS-CoV-2
Severe Acute Respiratory Syndrome*
Substances
Papain